Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 24, 2026
Why Is Nebius Group (NBIS) Stock Down -13.06% Today?

Why Is Nebius Group (NBIS) Stock Down -13.06% Today?

Key Takeaways

  • NBIS shares tumbled 13.06% on Friday, falling to $192.11 from a prior close of $220.97, as a broad risk-off rotation pummeled high-multiple AI infrastructure names.
  • No company-specific catalyst drove the sell-off. The decline reflected a sector-wide derating across neocloud and AI data center stocks, with peers like CoreWeave and IREN also down sharply.
  • Elevated volatility and profit-taking pressured high-beta growth equities after the VIX surged to its highest level in weeks, prompting institutional investors to trim positions in richly valued AI names.
  • Lingering Meta overhang continued to weigh on neocloud sentiment, as fears persist that Meta Platforms could monetize surplus AI compute capacity and compete directly with specialized cloud providers.
  • Analysts remain constructive despite the drawdown, with the consensus rating at Moderate Buy and an average price target of roughly $258, framing the decline as a technical event rather than a fundamental breakdown.

Opening Summary

Shares of NBIS, the Amsterdam-based AI cloud infrastructure company formerly carved out of Yandex, plummeted 13.06% in Friday trading to $192.11, erasing gains from earlier in the week. The stock had closed at $220.97 on Thursday, marking a single-session loss of $28.86 per share. Nebius Group, which builds and operates large-scale GPU clusters and full-stack AI cloud platforms for enterprise clients including Meta Platforms and Microsoft, found itself caught in a violent sector rotation as investors fled high-multiple AI infrastructure names amid a broader risk-off shift across technology markets.

Broad Neocloud Rout Drives the Sell-Off

Friday's decline was not an isolated event for NBIS but rather part of a sweeping unwind across the neocloud and AI data center ecosystem. CoreWeave (CRWV) dropped roughly 7%, IREN Limited (IREN) fell over 5%, and Cerebras Systems (CBRS) shed more than 10% on the same session. The synchronized selling underscored a thematic derating of pure-play AI infrastructure companies, which had been among the market's most richly valued and heavily traded growth stories throughout 2026. Unlike diversified cloud names such as Cloudflare (NET) and Snowflake (SNOW), which held relatively flat, the pure neocloud operators absorbed the brunt of the rotation, confirming that the highest-beta AI names were hit hardest when risk appetite soured.

Risk-Off Sentiment and Elevated Volatility

The macro backdrop turned notably less hospitable for speculative growth equities heading into Friday. The CBOE Volatility Index surged roughly 12% on Thursday to 18.7, its highest close in several weeks, signaling a meaningful uptick in investor anxiety. Against that environment, stocks trading at premium multiples became prime targets for institutional profit-taking. NBIS, which carries a trailing price-to-earnings ratio above 75 and a price-to-sales multiple exceeding 60, was especially vulnerable. With shares still up approximately 135% year-to-date and over 270% in the past 12 months, the pullback carried the hallmarks of a classic de-risking event rather than a reassessment of the company's underlying fundamentals.

Meta Overhang and Competitive Fears Persist

Adding a layer of structural anxiety, the neocloud sector has been under a cloud since early July, when Bloomberg reported that Meta Platforms (META) plans to monetize its excess AI computing capacity by entering the cloud infrastructure market. That disclosure triggered a 17% single-day drop in NBIS on July 1, and the competitive overhang has lingered ever since. Although Nebius holds a $27 billion AI infrastructure agreement with Meta itself—including $12 billion in committed capacity and up to $15 billion in flexible options—investors have wrestled with the possibility that the social media giant could evolve from anchor customer to direct competitor. Each attempted rebound in neocloud stocks over the past three weeks has met renewed selling pressure, indicating that the Meta narrative is not yet fully priced in.

Insider Selling and CapEx Concerns Add Friction

Compounding the macro and sector headwinds, recent insider transactions have weighed on market confidence. CEO Arkady Volozh, CTO Danila Shtan, and other senior executives have collectively sold more than $140 million worth of NBIS shares over the past quarter. While these sales were executed through pre-arranged trading plans and insiders retain substantial ownership positions, the optics of significant executive selling during a period of elevated stock prices have unsettled some institutional investors. Additionally, Nebius's revised 2026 capital expenditure forecast of $20 billion to $25 billion has drawn scrutiny, as the bulk of new infrastructure will not generate material revenue until early 2027, raising near-term concerns about cash burn and return on invested capital.

Market Context and Trading Activity

Volume in NBIS on Friday ran well below the average daily level, with approximately 3 million shares changing hands compared to a typical session volume of over 16 million. The lighter volume suggested that the sell-off was driven more by a withdrawal of bids than by panic liquidation, consistent with a rotational rather than a panic-driven move. The Nasdaq Composite and S&P 500 both traded lower, with weakness concentrated in the technology sector. From a technical standpoint, NBIS remains firmly below its 20-day and 50-day simple moving averages, though it continues to trade above its 200-day moving average near $157, indicating the longer-term uptrend remains intact despite the recent turbulence.

What Comes Next for NBIS

The near-term focus for NBIS investors shifts to the company's second-quarter earnings report, expected around August 6. Analysts are forecasting revenue of approximately $577 million and a loss of $0.73 per share, with the market likely to scrutinize updates on the asset-light partnership model, capacity deployment timelines, and any commentary on the competitive landscape. Broader sector catalysts include the trajectory of AI capital expenditure from hyperscalers and whether the VIX stabilizes below 17, which would support a return of risk appetite. Key risks include customer concentration, ongoing negative free cash flow during the infrastructure build-out phase, and the potential for Meta's cloud ambitions to materially alter the competitive dynamics of the neocloud industry.

Trending AI Robots

Amid volatile market conditions, traders seeking data-driven strategies may find value in Tickeron's Trending AI Robots page. Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers across diverse strategies, timeframes, and performance metrics. However, only the strongest performers under current market conditions are featured in the curated Trending AI Robots section. These bots vary by approach—from swing trading to trend following—and are designed to help traders identify opportunities without being swayed by emotional bias. Explore the Trending AI Robots to discover which strategies are excelling right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NBIS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


NBIS in +18.55% Uptrend, rising for three consecutive days on August 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NBIS advanced for three days, in of 138 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NBIS's RSI Oscillator exited the oversold zone, of 11 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NBIS just turned positive on August 03, 2026. Looking at past instances where NBIS's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

NBIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on August 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NBIS as a result. In of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NBIS moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NBIS crossed bearishly below the 50-day moving average on July 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBIS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NBIS entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NBIS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.658) is normal, around the industry mean (5.731). NBIS has a moderately high P/E Ratio (73.313) as compared to the industry average of (29.187). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (32.393). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (57.471) is also within normal values, averaging (70.644).

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Spotify Technology SA (NYSE:SPOT), Nebius Group N.V. (NASDAQ:NBIS), Baidu (NASDAQ:BIDU), Tencent Music Entertainment Group (NYSE:TME), Pinterest (NYSE:PINS), Snap (NYSE:SNAP), Bilibili (NASDAQ:BILI).

Industry description

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

Market Cap

The average market capitalization across the Internet Software/Services Industry is 146.87B. The market cap for tickers in the group ranges from 2.69K to 4.37T. GOOGL holds the highest valuation in this group at 4.37T. The lowest valued company is STBXF at 2.69K.

High and low price notable news

The average weekly price growth across all stocks in the Internet Software/Services Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -5%. AREN experienced the highest price growth at 35%, while ONFO experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Internet Software/Services Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 73
Price Growth Rating: 61
SMR Rating: 79
Profit Risk Rating: 94
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
NBIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an investment holding company with interest in providing internet search engine services

Industry InternetSoftwareServices

Profile
Details
Industry
Internet Software Or Services
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.